These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
241 related items for PubMed ID: 6148252
1. Differential inhibition by dopamine D-1 and D-2 antagonists of circling behaviour induced by dopamine agonists in rats with unilateral 6-hydroxydopamine lesions. Arnt J, Hyttel J. Eur J Pharmacol; 1984 Jul 13; 102(2):349-54. PubMed ID: 6148252 [Abstract] [Full Text] [Related]
2. Differential involvement of dopamine D-1 and D-2 receptors in the circling behaviour induced by apomorphine, SK & F 38393, pergolide and LY 171555 in 6-hydroxydopamine-lesioned rats. Arnt J, Hyttel J. Psychopharmacology (Berl); 1985 Jul 13; 85(3):346-52. PubMed ID: 2860689 [Abstract] [Full Text] [Related]
3. Behavioural stimulation is induced by separate dopamine D-1 and D-2 receptor sites in reserpine-pretreated but not in normal rats. Arnt J. Eur J Pharmacol; 1985 Jul 11; 113(1):79-88. PubMed ID: 2931283 [Abstract] [Full Text] [Related]
4. Hyperactivity induced by stimulation of separate dopamine D-1 and D-2 receptors in rats with bilateral 6-OHDA lesions. Arnt J. Life Sci; 1985 Aug 26; 37(8):717-23. PubMed ID: 3927097 [Abstract] [Full Text] [Related]
5. Differential effects of dopamine D-1 and D-2 agonists and antagonists in 6-hydroxydopamine-lesioned rats. Arnt J. Psychopharmacology Suppl; 1985 Aug 26; 2():60-1. PubMed ID: 3159011 [No Abstract] [Full Text] [Related]
6. Inhibition of SKF 38393- and pergolide-induced circling in rats with unilateral 6-OHDA lesion is correlated to dopamine D-1 and D-2 receptor affinities in vitro. Arnt J, Hyttel J. J Neural Transm; 1986 Aug 26; 67(3-4):225-40. PubMed ID: 2949056 [Abstract] [Full Text] [Related]
7. Selective inactivation of dopamine D1 and D2 receptors in 6-hydroxydopamine-lesioned rats: evidence that the effect of D1 and D2 agonists can be expressed in the absence of the heterologous DA receptor. Arnt J, Hyttel J. Pharmacol Toxicol; 1989 Jan 26; 64(1):116-9. PubMed ID: 2526946 [Abstract] [Full Text] [Related]
8. Role of the substantia nigra in the expression of dopamine D1 receptor-mediated and D2 receptor-mediated behaviours. Fletcher GH, Starr MS. Neuroscience; 1987 Dec 26; 23(3):1001-10. PubMed ID: 2963970 [Abstract] [Full Text] [Related]
10. Synergistic interaction between dopamine D-1 and D-2 receptor agonists: circling behaviour of rats with hemitransection. Arnt J, Perregaard J. Eur J Pharmacol; 1987 Nov 03; 143(1):45-53. PubMed ID: 3500865 [Abstract] [Full Text] [Related]
11. Repeated stimulation of D-1 dopamine receptors increases the circling response to bromocriptine in rats with a 6-OHDA lesion. Rouillard C, Bédard P, Falardeau P, Di Paolo T. Eur J Pharmacol; 1988 Nov 22; 157(2-3):125-33. PubMed ID: 2975996 [Abstract] [Full Text] [Related]
12. Behavioural evidence for the functionality of D-2 but not D-1 dopamine receptors at multiple brain sites in the 6-hydroxydopamine-lesioned rat. Fletcher GH, Starr MS. Eur J Pharmacol; 1987 Jun 26; 138(3):407-11. PubMed ID: 2957221 [Abstract] [Full Text] [Related]
13. Dopamine D-1 receptor agonists combined with the selective D-2 agonist quinpirole facilitate the expression of oral stereotyped behaviour in rats. Arnt J, Hyttel J, Perregaard J. Eur J Pharmacol; 1987 Jan 13; 133(2):137-45. PubMed ID: 2949991 [Abstract] [Full Text] [Related]
14. Selective protection from the inhibition by EEDQ of D1 and D2 dopamine agonist-induced rotational behavior in mice. Goodale DB, Jacobi AG, Seyfried DM, Weiss B. Pharmacol Biochem Behav; 1988 Jun 13; 30(2):457-62. PubMed ID: 2902647 [Abstract] [Full Text] [Related]
15. Relative dopamine D1 and D2 receptor affinity and efficacy determine whether dopamine agonists induce hyperactivity or oral stereotypy in rats. Arnt J, Bøgesø KP, Hyttel J, Meier E. Pharmacol Toxicol; 1988 Mar 13; 62(3):121-30. PubMed ID: 3259694 [Abstract] [Full Text] [Related]
16. Dopamine agonist-induced locomotor activity in rats treated with 6-hydroxydopamine at differing ages: functional supersensitivity of D-1 dopamine receptors in neonatally lesioned rats. Breese GR, Napier TC, Mueller RA. J Pharmacol Exp Ther; 1985 Aug 13; 234(2):447-55. PubMed ID: 3926987 [Abstract] [Full Text] [Related]
17. Specific D1 and D2 dopamine agonists have synergistic effects in the 6-hydroxydopamine circling model in the rat. Rouillard C, Bédard PJ. Neuropharmacology; 1988 Dec 13; 27(12):1257-64. PubMed ID: 2907616 [Abstract] [Full Text] [Related]
18. Agonist-induced homologous and heterologous sensitization to D-1- and D-2-dependent contraversive turning. Morelli M, Di Chiara G. Eur J Pharmacol; 1987 Sep 02; 141(1):101-7. PubMed ID: 3117576 [Abstract] [Full Text] [Related]
19. Pharmacological evaluation of SCH-12679: evidence for an in vivo antagonism of D1-dopamine receptors. Breese GR, Criswell HE, McQuade RD, Iorio LC, Mueller RA. J Pharmacol Exp Ther; 1990 Feb 02; 252(2):558-67. PubMed ID: 1968972 [Abstract] [Full Text] [Related]
20. Climbing and stereotyped behaviours in mice require the stimulation of D-1 dopamine receptors. Vasse M, Chagraoui A, Protais P. Eur J Pharmacol; 1988 Mar 29; 148(2):221-9. PubMed ID: 2897924 [Abstract] [Full Text] [Related] Page: [Next] [New Search]